These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 12088354

  • 1. Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials.
    Chew DP, Bhatt DL.
    Intern Med J; 2002 Jul; 32(7):338-45. PubMed ID: 12088354
    [Abstract] [Full Text] [Related]

  • 2. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
    Batchelor WB, Tolleson TR, Huang Y, Larsen RL, Mantell RM, Dillard P, Davidian M, Zhang D, Cantor WJ, Sketch MH, Ohman EM, Zidar JP, Gretler D, DiBattiste PM, Tcheng JE, Califf RM, Harrington RA.
    Circulation; 2002 Sep 17; 106(12):1470-6. PubMed ID: 12234950
    [Abstract] [Full Text] [Related]

  • 3. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Bhatt DL, Topol EJ.
    JAMA; 2000 Sep 27; 284(12):1549-58. PubMed ID: 11000650
    [Abstract] [Full Text] [Related]

  • 4. Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
    Proimos G.
    J Thromb Thrombolysis; 2001 Apr 27; 11(2):99-110. PubMed ID: 11406724
    [Abstract] [Full Text] [Related]

  • 5. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW.
    Am J Cardiol; 1999 Aug 15; 84(4):391-5. PubMed ID: 10468074
    [Abstract] [Full Text] [Related]

  • 6. High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists.
    Kereiakes DJ, Broderick TM, Roth EM, Whang D, Mueller M, Lacock P, Anderson LC, Howard W, Blanck C, Schneider J, Abbottsmith CA.
    J Thromb Thrombolysis; 2000 Feb 15; 9(2):149-55. PubMed ID: 10613996
    [Abstract] [Full Text] [Related]

  • 7. TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention.
    Kandzari DE, Califf RM.
    Curr Opin Cardiol; 2002 Jul 15; 17(4):332-9. PubMed ID: 12151865
    [Abstract] [Full Text] [Related]

  • 8. IIb's are not IIb's.
    Kereiakes DJ, Runyon JP, Broderick TM, Shimshak TM.
    Am J Cardiol; 2000 Apr 27; 85(8A):23C-31C. PubMed ID: 10793177
    [Abstract] [Full Text] [Related]

  • 9. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
    Boersma E, Akkerhuis KM, Théroux P, Califf RM, Topol EJ, Simoons ML.
    Circulation; 1999 Nov 16; 100(20):2045-8. PubMed ID: 10562258
    [Abstract] [Full Text] [Related]

  • 10. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.
    Herz; 2003 Aug 16; 28(5):393-403. PubMed ID: 12928738
    [Abstract] [Full Text] [Related]

  • 11. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial.
    Cannon CP.
    J Am Coll Cardiol; 2003 Feb 19; 41(4 Suppl S):43S-48S. PubMed ID: 12644340
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
    Hobbach HP, Schuster P.
    Z Kardiol; 2003 Mar 19; 92(3):213-8. PubMed ID: 12658467
    [Abstract] [Full Text] [Related]

  • 13. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
    Lincoff AM, Califf RM, Topol EJ.
    J Am Coll Cardiol; 2000 Apr 19; 35(5):1103-15. PubMed ID: 10758948
    [Abstract] [Full Text] [Related]

  • 14. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM.
    Am Heart J; 1999 Oct 19; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [Abstract] [Full Text] [Related]

  • 15. The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis.
    Glaser R, Glick HA, Herrmann HC, Kimmel SE.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):529-37. PubMed ID: 16458131
    [Abstract] [Full Text] [Related]

  • 16. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Am Heart J; 1998 Apr 07; 135(4):S43-55. PubMed ID: 9539495
    [Abstract] [Full Text] [Related]

  • 17. Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.
    Tcheng JE.
    Am J Cardiol; 1996 Aug 14; 78(3A):35-40. PubMed ID: 8751845
    [Abstract] [Full Text] [Related]

  • 18. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
    Memon MA, Blankenship JC, Wood GC, Frey CM, Menapace FJ.
    Am J Med; 2000 Aug 15; 109(3):213-7. PubMed ID: 10974184
    [Abstract] [Full Text] [Related]

  • 19. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E, Dykun Y, van den Brand MJ, van der Wieken LR, Simoons ML.
    Eur Heart J; 1998 Nov 15; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract] [Full Text] [Related]

  • 20. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
    Araujo R, Agustí A.
    Med Clin (Barc); 2000 Oct 07; 115(11):435-7. PubMed ID: 11093849
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.